Grufity logoGrufity logo

CVS Health Corp Stock Research

CVS

73.18USD-1.23(-1.65%)Market Closed

Market Summary

USD73.18-1.23
Market Closed
-1.65%

CVS Alerts

CVS Stock Price

CVS RSI Chart

CVS Valuation

Market Cap

95.1B

Price/Earnings (Trailing)

22.93

Price/Sales (Trailing)

0.3

EV/EBITDA

10.91

Price/Free Cashflow

7.07

CVS Price/Sales (Trailing)

CVS Profitability

EBT Margin

1.75%

Return on Equity

5.84%

Return on Assets

1.82%

Free Cashflow Yield

14.14%

CVS Fundamentals

CVS Revenue

Revenue (TTM)

322.5B

Revenue Y/Y

9.45%

Revenue Q/Q

3.31%

CVS Earnings

Earnings (TTM)

4.1B

Earnings Y/Y

76.26%

Earnings Q/Q

167.39%

Price Action

52 Week Range

73.17107.03
(Low)(High)

Last 7 days

-5.5%

Last 30 days

-16.1%

Last 90 days

-22.7%

Trailing 12 Months

-28.3%

CVS Financial Health

Current Ratio

0.94

Debt/Equity

0.71

Debt/Cashflow

0.32

CVS Investor Care

Dividend Yield

3.01%

Dividend/Share (TTM)

2.2

Buy Backs (1Y)

1.66%

Diluted EPS (TTM)

3.14

Peers (Alternatives to CVS Health)

View All Peers In Detail
NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
441.5B
324.2B
-6.04% -5.61%
21.94
1.36
12.71% 16.40%
95.1B
322.5B
-16.10% -28.31%
22.93
0.3
10.39% -47.55%
91.1B
180.5B
-9.45% 16.50%
13.64
1.92
3.70% 24.58%
62.6B
92.9B
-3.60% 10.39%
22.3
0.67
11.81% -4.33%
34.4B
144.5B
-13.05% -25.78%
28.66
0.24
14.74% -10.76%
MID-CAP
5.6B
3.9B
7.58% 19.99%
37.42
1.43
14.72% 7.62%
5.2B
2.3B
3.17% 35.63%
86.23
2.28
2.85% -58.05%
4.9B
831.2M
-11.67% 3.11%
-82.63
5.84
12.11% -862.52%
2.9B
4.6B
0.72% 13.28%
-225.79
0.63
2.45% 84.88%
2.6B
6.4B
-14.06% -14.67%
13.12
0.4
-0.52% 17.01%
SMALL-CAP
1.6B
-
0.59% 17.88%
18.77
3.24
- -
1.6B
951.1M
-7.28% 30.41%
35.03
1.7
10.02% 1.99%
1.2B
1.4B
12.22% 10.36%
115.9
0.86
8.74% -56.93%
449.4M
2.8B
-3.12% -59.80%
-1.88
0.16
2.43% -140.13%
242.8M
96.2M
2.80% -48.48%
898.97
2.52
26.92% -98.46%

Financials for CVS Health

Income Statement (Last 12 Months)
(In Millions)
* denotes actual numbers (not divided by Millions)
Description(%) Q/Q2022Q42022Q32022Q22022Q12021Q4
Revenue2.3%322,467315,225307,860299,840292,111
Operating Expenses1.6%38,09437,490---
EBITDA13.2%12,16210,74517,46017,269-
EBITDA Margin10.6%0.04*0.03*0.06*0.06*-
Earnings Before Taxes37.6%5,6284,08910,69010,39610,420
EBT Margin34.5%0.02*0.01*0.03*0.03*-
Interest Expenses-2.4%2,2872,3432,3792,4322,503
Net Income31.1%4,1493,1648,1788,0087,910
Net Income Margin28.2%0.01*0.01*0.03*0.03*-
Free Cahsflow-31.0%13,45019,49815,86816,194-
Balance Sheet
(In Millions)
* denotes actual numbers (not divided by Millions)
Description(%) Q/Q2022Q42022Q32022Q22022Q12021Q4
Assets-1.3%228,275231,212230,279232,873232,999
  Current Assets-3.9%65,68268,34162,14261,48360,008
    Cash Equivalents-24.7%12,94517,19712,1168,4429,408
  Inventory5.7%19,09018,05817,37518,16017,760
  Net PPE2.0%12,87312,62612,76412,84412,896
  Goodwill0.1%78,15078,08678,56079,06079,121
Liabilities-2.0%156,960160,201154,773158,733157,618
  Current Liabilities-3.7%69,73672,40968,45769,78067,807
  Long Term Debt-0.7%50,47650,84850,79752,06351,971
Shareholder's Equity0.5%71,01570,68375,50674,14075,075
  Retained Earnings2.9%56,14554,57158,71056,48854,906
Accumulated Depreciation-20,654----
Shares Outstanding-1.1%1,3001,3151,3121,3061,322
Minority Interest-8.5%300328322310306
Cashflow (Last 12 Months)
(In Millions)
* denotes actual numbers (not divided by Millions)
Description(%) Q/Q2022Q42022Q32022Q22022Q12021Q4
Cashflow From Operations-26.9%16,17722,13418,53218,93618,265
  Share Based Compensation-6.7%447479488486484
Cashflow From Investing20.7%-5,047-6,368-6,410-5,387-5,261
Cashflow From Financing6.5%-10,516-11,243-9,955-10,821-11,356
  Dividend Payments2.1%2,9072,8482,7812,6912,625
  Buy Backs75.0%3,5002,0002,0002,0000.00

Risks for CVS

What is the probability of a big loss on CVS?

58.1%


Probability that CVS Health stock will be more than 20% underwater in next one year

14.2%


Probability that CVS Health stock will be more than 30% underwater in next one year.

0%


Probability that CVS Health stock will be more than 40% underwater in next one year.
*Calculated based on probability distribution of losses observed in actual data in the last 5 years.

How does CVS drawdown profile look like?

Y-axis is the maximum loss one would have experienced if CVS Health was unfortunately bought at previous high price.

Drawdowns

Returns for CVS

Cumulative Returns on CVS

5.8%


10-Year Cumulative Returns

-1.6%


7-Year Cumulative Returns

5.6%


5-Year Cumulative Returns

10.8%


3-Year Cumulative Returns

What are the long-term rolling returns for CVS?

FIve years rolling returns for CVS Health.

Annualized Returns

Which funds bought or sold CVS recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
2023-03-15
B. Riley Wealth Advisors, Inc.
added
3.06
55,130
8,103,130
0.23%
2023-03-13
Claro Advisors LLC
added
18.81
216,324
1,327,320
0.43%
2023-03-10
MATHER GROUP, LLC.
reduced
-3.66
-63,602
1,016,400
0.02%
2023-03-10
VICTORY CAPITAL MANAGEMENT INC
reduced
-5.03
-8,247,480
106,282,000
0.12%
2023-03-08
Capital Asset Advisory Services LLC
reduced
-7.88
-127,522
1,373,480
0.11%
2023-03-08
SHEETS SMITH WEALTH MANAGEMENT
reduced
-2.76
-61,984
1,191,020
0.19%
2023-03-07
Great Lakes Retirement, Inc.
new
-
648,748
648,748
0.17%
2023-03-06
Rockefeller Capital Management L.P.
added
5.11
1,905,000
72,371,000
0.36%
2023-03-03
TIAA, FSB
added
10.8
411,003
5,382,000
0.02%
2023-03-03
Crumly & Associates Inc.
reduced
-5.02
-46,050
591,950
0.22%

1–10 of 45

Latest Funds Activity

Are funds buying CVS calls or puts?
Calls
Puts
Are funds bullish or bearish(Calls - Puts)?
Net Call Options
No. of funds that own CVS
No. of Funds

CVS Health News

MarketWatch

Cigna Group stock falls Thursday, underperforms market.

MarketWatch,
3 minutes ago

Home Health Care News

FierceHealthcare

Stock Traders Daily

Seeking Alpha

Benzinga

InvestorsObserver

Crain's Chicago Business

Oak Street Health launches dialysis venture Oakwell.

Crain's Chicago Business,
22 hours ago

Schedule 13G FIlings of CVS Health

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 09, 2023
vanguard group inc
8.94%
117,533,372
SC 13G/A
Feb 07, 2023
blackrock inc.
7.4%
96,668,258
SC 13G/A
Feb 09, 2022
vanguard group inc
8.28%
109,236,922
SC 13G/A
Feb 01, 2022
blackrock inc.
7.1%
93,556,500
SC 13G/A
Feb 10, 2021
vanguard group inc
8.05%
105,383,923
SC 13G/A
Jan 29, 2021
blackrock inc.
7.1%
92,478,369
SC 13G/A
Feb 12, 2020
vanguard group inc
8.05%
104,808,202
SC 13G/A
Feb 05, 2020
blackrock inc.
7.2%
94,158,010
SC 13G/A

CVS Fair Value

CVS Health fair value in different scenarios

The table shows the Fair Value estimates for CVS Health for various scenarios. Disclaimer: These are just estimations from a model. None of the models are good at predicting the future. Please dont buy or sell stocks based on these outputs.
Fair ValueVery PessimisticPessimisticBase CaseOptimisticVery Optimistic
Very Low Inflation

123.17

68.31%

150.44

105.58%

201.10

174.80%

258.39

253.09%

323.05

341.45%
Current Inflation

113.28

54.80%

136.37

86.35%

178.69

144.18%

226.45

209.44%

280.46

283.25%
Very High Inflation

101.12

38.18%

119.41

63.17%

152.32

108.14%

189.45

158.88%

231.59

216.47%

Historical CVS Health Fair Value Estimates


Very Pessimistic Case
Pessimistic Case
Fair Value
Optimistic Case
Very Optimistic Case
Closing Stock Price

Recent SEC filings of CVS Health

View All Filings
Date Filed Form Type Document
Mar 07, 2023
DFAN14A
DFAN14A
Mar 01, 2023
4
Insider Trading
Mar 01, 2023
4
Insider Trading
Mar 01, 2023
4
Insider Trading
Mar 01, 2023
4
Insider Trading
Mar 01, 2023
4
Insider Trading
Mar 01, 2023
4
Insider Trading
Mar 01, 2023
4
Insider Trading
Feb 21, 2023
8-K
Current Report
Feb 15, 2023
3
Insider Trading

Latest Insider Trading transactions for CVS

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
2023-02-28
Clark James David
sold (taxes)
-14,953
83.54
-179
svp, cont & chief acct officer
2023-02-28
Chaguturu Sreekanth K
sold (taxes)
-10,024
83.54
-120
evp and chief medical officer
2023-02-28
Khichi Samrat S.
acquired
3,999,980
83.54
47,881
evp, cpo and general counsel
2023-02-28
Joyner J. David
acquired
1,999,950
83.54
23,940
evp&president-pharmacyservices
2023-02-27
Chaguturu Sreekanth K
sold (taxes)
-27,274
85.77
-318
evp and chief medical officer
2023-02-27
Havanec Laurie P.
sold (taxes)
-347,025
85.77
-4,046
evp and chief people officer
2023-02-27
Shah Prem S
sold (taxes)
-19,384
85.77
-226
evp and co-president of retail
2023-02-27
PELUSO MICHELLE A
sold (taxes)
-1,055,310
85.77
-12,304
evp and co-president of retail
2023-02-02
PELUSO MICHELLE A
acquired
-
-
192,554
evp and co-president of retail
2023-02-02
Lynch Karen S
acquired
-
-
206,610
president and ceo

1–10 of 50

Karen S. Lynch
65535
CVS Health Corporation provides health services in the United States. The company's Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. Its Pharmacy Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, clinical, and disease and medical spend management services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, plans offered on public health insurance and private health insurance exchanges, other sponsors of health benefit plans, and individuals. This segment operates retail specialty pharmacy stores; and specialty mail-order, mail-order dispensing, and compounding pharmacies, as well as branches for infusion and enteral nutrition services. The company's Retail/LTC segment sells prescription and over-the-counter drugs, consumer health and beauty products, and personal care products; and provides health care services through its MinuteClinic walk-in medical clinics. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. As of December 31, 2021, it operated approximately 9,900 retail locations and 1,200 MinuteClinic locations, as well as online retail pharmacy websites, LTC pharmacies, and onsite pharmacies. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1963 and is headquartered in Woonsocket, Rhode Island.

CVS Income Statement

2022-09-30
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
shares in Millions, $ in Millions
3 Months Ended9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Revenues:    
Premiums$ 21,003$ 18,984$ 63,894$ 56,927
Net investment income201246515832
Total revenues81,15973,794238,621215,507
Operating costs:    
Cost of products sold50,36545,011145,164129,425
Benefit costs17,41916,08152,97647,686
Opioid litigation charges5,22005,7040
Loss on assets held for sale2,48002,5210
Goodwill impairment04310431
Operating expenses9,6069,21028,12827,001
Total operating costs85,09070,733234,493204,543
Operating income (loss)(3,931)3,0614,12810,964
Interest expense5666021,7351,895
Loss on early extinguishment of debt03630363
Other income(41)(49)(126)(144)
Income (loss) before income tax provision(4,456)2,1452,5198,850
Income tax provision (benefit)(1,047)5586542,248
Net income (loss)(3,409)1,5871,8656,602
Net (income) loss attributable to noncontrolling interests(7)11(18)2
Net income (loss) attributable to CVS Health$ (3,416)$ 1,598$ 1,847$ 6,604
Net income (loss) per share attributable to CVS Health:    
Basic (in dollars per share)$ (2.60)$ 1.21$ 1.41$ 5.01
Diluted (in dollars per share)$ (2.60)$ 1.20$ 1.40$ 4.98
Weighted average shares outstanding:    
Basic (in shares)1,3151,3211,3131,318
Diluted (in shares)1,3151,3291,3241,326
Dividends declared per share (in dollars per share)$ 0.55$ 0.50$ 1.65$ 1.50
Cost, Product and Service [Extensible List]ProductsProductsProductsProducts
Products    
Revenues:    
Revenues$ 57,643$ 51,853$ 166,959$ 149,765
Services    
Revenues:    
Revenues$ 2,312$ 2,711$ 7,253$ 7,983

CVS Balance Sheet

2022-09-30
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Millions
Sep. 30, 2022
Dec. 31, 2021
Assets:  
Cash and cash equivalents$ 17,197$ 9,408
Investments2,7923,117
Accounts receivable, net26,31724,431
Inventories18,05817,760
Assets held for sale1,4980
Other current assets2,4795,292
Total current assets68,34160,008
Long-term investments20,56523,025
Property and equipment, net12,62612,896
Operating lease right-of-use assets18,27019,122
Goodwill78,08679,121
Intangible assets, net25,15729,026
Separate accounts assets3,3185,087
Other assets4,8494,714
Total assets231,212232,999
Liabilities:  
Accounts payable13,92512,544
Pharmacy claims and discounts payable19,16117,330
Health care costs payable10,3518,808
Policyholders’ funds1,6424,301
Accrued expenses19,42317,670
Other insurance liabilities4,5611,303
Current portion of operating lease liabilities1,6871,646
Current portion of long-term debt1,3634,205
Liabilities held for sale2960
Total current liabilities72,40967,807
Long-term operating lease liabilities17,17418,177
Long-term debt50,84851,971
Deferred income taxes3,5086,270
Separate accounts liabilities3,3185,087
Other long-term insurance liabilities6,1756,402
Other long-term liabilities6,7691,904
Total liabilities160,201157,618
Shareholders’ equity:  
Preferred stock, par value $0.01: 0.1 shares authorized; none issued or outstanding00
Common stock, par value $0.01: 3,200 shares authorized; 1,757 shares issued and 1,315 shares outstanding at September 30, 2022 and 1,744 shares issued and 1,322 shares outstanding at December 31, 2021 and capital surplus48,04747,377
Treasury stock, at cost: 442 shares at September 30, 2022 and 422 shares at December 31, 2021(30,326)(28,173)
Retained earnings54,57154,906
Accumulated other comprehensive income (loss)(1,609)965
Total CVS Health shareholders’ equity70,68375,075
Noncontrolling interests328306
Total shareholders’ equity71,01175,381
Total liabilities and shareholders’ equity$ 231,212$ 232,999